In HCC, the activation of MEK/ERK pathway is supportive for tumour progression by promoting cellular proliferation and survival, tumour growth, cell motility, invasiveness and angiogenesis.35 The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.